Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for ELF2_GABPA_ELF5
Z-value: 2.24
Motif logo
Transcription factors associated with ELF2_GABPA_ELF5
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ELF2
|
ENSG00000109381.15 | E74 like ETS transcription factor 2 |
|
GABPA
|
ENSG00000154727.6 | GA binding protein transcription factor subunit alpha |
|
ELF5
|
ENSG00000135374.5 | E74 like ETS transcription factor 5 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| GABPA | hg19_v2_chr21_+_27107672_27107698 | 0.94 | 5.7e-10 | Click! |
| ELF5 | hg19_v2_chr11_-_34535332_34535352 | 0.55 | 1.2e-02 | Click! |
| ELF2 | hg19_v2_chr4_-_140005443_140005650 | 0.33 | 1.5e-01 | Click! |
Activity profile of ELF2_GABPA_ELF5 motif
Sorted Z-values of ELF2_GABPA_ELF5 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of ELF2_GABPA_ELF5
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.6 | 26.2 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 2.3 | 9.3 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
| 2.3 | 6.8 | GO:1903249 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 1.9 | 19.4 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 1.9 | 7.8 | GO:0016333 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 1.9 | 19.1 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 1.6 | 14.7 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 1.6 | 7.9 | GO:1901545 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 1.6 | 10.9 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 1.5 | 7.6 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 1.5 | 6.0 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 1.5 | 17.5 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 1.4 | 4.3 | GO:0033341 | regulation of collagen binding(GO:0033341) |
| 1.4 | 1.4 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 1.4 | 8.5 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 1.4 | 5.7 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 1.4 | 5.5 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 1.3 | 6.6 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
| 1.3 | 3.9 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
| 1.3 | 6.5 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 1.3 | 11.3 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
| 1.3 | 5.0 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 1.2 | 8.5 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 1.2 | 13.1 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 1.2 | 3.6 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 1.2 | 3.5 | GO:1904316 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 1.2 | 3.5 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 1.1 | 1.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 1.1 | 5.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 1.1 | 1.1 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
| 1.1 | 3.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 1.1 | 3.3 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 1.1 | 6.5 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 1.1 | 5.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 1.1 | 9.6 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 1.1 | 4.2 | GO:0032418 | lysosome localization(GO:0032418) |
| 1.1 | 5.3 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 1.0 | 7.3 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 1.0 | 3.1 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 1.0 | 3.1 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 1.0 | 4.1 | GO:0060166 | olfactory pit development(GO:0060166) |
| 1.0 | 1.0 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 1.0 | 3.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 1.0 | 4.0 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 1.0 | 2.9 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 1.0 | 4.9 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 1.0 | 2.9 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 1.0 | 3.8 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.9 | 6.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.9 | 4.7 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.9 | 3.7 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.9 | 2.8 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
| 0.9 | 4.6 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.9 | 6.5 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.9 | 0.9 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
| 0.9 | 3.6 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.9 | 5.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.9 | 2.7 | GO:0031106 | septin ring assembly(GO:0000921) septin ring organization(GO:0031106) |
| 0.9 | 3.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.9 | 2.7 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.9 | 0.9 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.9 | 3.5 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.9 | 1.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.9 | 2.6 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.9 | 1.7 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.9 | 0.9 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
| 0.9 | 5.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.9 | 4.3 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.9 | 5.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.9 | 4.3 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.9 | 2.6 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.8 | 17.8 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.8 | 3.4 | GO:0035350 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.8 | 2.5 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.8 | 2.5 | GO:0001300 | chronological cell aging(GO:0001300) |
| 0.8 | 3.3 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.8 | 5.0 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
| 0.8 | 4.2 | GO:1904764 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.8 | 5.0 | GO:0030047 | actin modification(GO:0030047) |
| 0.8 | 11.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.8 | 4.1 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.8 | 3.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.8 | 0.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.8 | 6.5 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.8 | 2.4 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.8 | 2.4 | GO:0007388 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.8 | 3.9 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.8 | 3.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.8 | 2.3 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.8 | 9.9 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.8 | 2.3 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
| 0.8 | 2.3 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.7 | 6.0 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.7 | 2.2 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.7 | 3.0 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.7 | 5.2 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
| 0.7 | 5.9 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.7 | 4.4 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.7 | 4.4 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.7 | 0.7 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.7 | 2.2 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.7 | 7.8 | GO:0060717 | chorion development(GO:0060717) |
| 0.7 | 9.2 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
| 0.7 | 3.5 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.7 | 4.2 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
| 0.7 | 4.9 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.7 | 2.8 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.7 | 0.7 | GO:0070141 | response to UV-A(GO:0070141) |
| 0.7 | 0.7 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
| 0.7 | 2.1 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
| 0.7 | 2.1 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
| 0.7 | 7.6 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 0.7 | 2.1 | GO:0070781 | response to biotin(GO:0070781) |
| 0.7 | 6.2 | GO:0030242 | pexophagy(GO:0030242) |
| 0.7 | 6.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.7 | 2.0 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.7 | 6.8 | GO:0043622 | cortical microtubule organization(GO:0043622) |
| 0.7 | 7.5 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.7 | 8.1 | GO:0032202 | telomere assembly(GO:0032202) |
| 0.7 | 0.7 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.7 | 4.7 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.7 | 2.7 | GO:1905216 | positive regulation of RNA binding(GO:1905216) |
| 0.7 | 0.7 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
| 0.7 | 3.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.7 | 2.0 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.7 | 2.0 | GO:1902811 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.7 | 20.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.7 | 4.6 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.7 | 11.7 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.6 | 11.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
| 0.6 | 1.9 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 0.6 | 1.9 | GO:0070631 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.6 | 1.9 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.6 | 3.8 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.6 | 5.7 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.6 | 1.9 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 0.6 | 2.5 | GO:0014003 | oligodendrocyte development(GO:0014003) |
| 0.6 | 1.9 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.6 | 1.3 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 0.6 | 5.0 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.6 | 3.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.6 | 4.4 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.6 | 3.7 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.6 | 1.8 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
| 0.6 | 1.8 | GO:1902559 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.6 | 4.3 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.6 | 12.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.6 | 3.7 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.6 | 3.7 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.6 | 1.8 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.6 | 1.2 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.6 | 2.4 | GO:0051808 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.6 | 1.8 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.6 | 7.7 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.6 | 3.0 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 0.6 | 3.6 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.6 | 2.4 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.6 | 3.6 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.6 | 2.4 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
| 0.6 | 5.3 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.6 | 1.8 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.6 | 0.6 | GO:0046832 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.6 | 0.6 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 0.6 | 21.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.6 | 2.3 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
| 0.6 | 8.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.6 | 2.3 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.6 | 3.4 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.6 | 30.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.6 | 1.7 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.6 | 1.7 | GO:0035698 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.6 | 1.7 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.6 | 1.7 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 0.6 | 2.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.5 | 2.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.5 | 2.2 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.5 | 8.8 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.5 | 3.8 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.5 | 1.1 | GO:0070662 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
| 0.5 | 3.8 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
| 0.5 | 3.8 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.5 | 2.2 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.5 | 3.2 | GO:0043366 | beta selection(GO:0043366) |
| 0.5 | 2.7 | GO:0035936 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.5 | 4.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.5 | 0.5 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 0.5 | 1.6 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.5 | 2.6 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.5 | 0.5 | GO:0044772 | mitotic cell cycle phase transition(GO:0044772) |
| 0.5 | 3.1 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.5 | 1.6 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.5 | 3.7 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.5 | 7.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.5 | 4.1 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.5 | 1.5 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 0.5 | 1.0 | GO:0016572 | histone phosphorylation(GO:0016572) |
| 0.5 | 0.5 | GO:1904875 | regulation of DNA ligase activity(GO:1904875) |
| 0.5 | 2.0 | GO:0071284 | cellular response to lead ion(GO:0071284) |
| 0.5 | 4.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.5 | 3.0 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.5 | 2.0 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.5 | 3.4 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.5 | 1.0 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
| 0.5 | 7.8 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.5 | 3.9 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.5 | 1.5 | GO:0006429 | leucyl-tRNA aminoacylation(GO:0006429) |
| 0.5 | 3.9 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.5 | 1.9 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.5 | 4.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.5 | 2.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.5 | 1.0 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.5 | 1.9 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 0.5 | 4.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.5 | 3.8 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
| 0.5 | 2.9 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.5 | 1.4 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 0.5 | 4.3 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.5 | 8.5 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.5 | 2.8 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.5 | 1.9 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.5 | 1.9 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.5 | 1.9 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.5 | 0.5 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
| 0.5 | 11.7 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.5 | 0.5 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 0.5 | 16.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.5 | 0.9 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 0.5 | 0.9 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.5 | 1.9 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.5 | 2.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.5 | 1.8 | GO:0051413 | response to cortisone(GO:0051413) |
| 0.5 | 0.5 | GO:0032886 | regulation of microtubule-based process(GO:0032886) |
| 0.5 | 4.1 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.5 | 2.3 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.5 | 7.8 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
| 0.5 | 1.4 | GO:0010160 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.5 | 0.9 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.5 | 4.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.5 | 0.9 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) formation of anatomical boundary(GO:0048859) |
| 0.4 | 5.4 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.4 | 0.9 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.4 | 9.8 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.4 | 1.3 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 0.4 | 3.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.4 | 1.8 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.4 | 4.4 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
| 0.4 | 4.4 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
| 0.4 | 7.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.4 | 1.3 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.4 | 2.6 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.4 | 1.7 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.4 | 0.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.4 | 1.3 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
| 0.4 | 1.7 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.4 | 1.7 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.4 | 2.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.4 | 1.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
| 0.4 | 4.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.4 | 3.8 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.4 | 2.5 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.4 | 0.4 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.4 | 3.3 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.4 | 0.8 | GO:0021764 | amygdala development(GO:0021764) |
| 0.4 | 0.4 | GO:0060733 | regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
| 0.4 | 1.2 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 0.4 | 2.5 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.4 | 9.5 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.4 | 0.8 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
| 0.4 | 1.2 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.4 | 0.4 | GO:1902164 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.4 | 2.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.4 | 1.6 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.4 | 1.2 | GO:0006043 | glucosamine catabolic process(GO:0006043) |
| 0.4 | 2.8 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 0.4 | 2.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.4 | 4.4 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.4 | 2.4 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.4 | 4.8 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.4 | 2.4 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
| 0.4 | 2.0 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
| 0.4 | 1.2 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.4 | 5.5 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.4 | 4.7 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.4 | 1.2 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.4 | 0.4 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
| 0.4 | 1.2 | GO:0021896 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.4 | 5.0 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.4 | 2.7 | GO:0060992 | response to fungicide(GO:0060992) |
| 0.4 | 5.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.4 | 0.8 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 0.4 | 1.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.4 | 1.9 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
| 0.4 | 3.1 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
| 0.4 | 2.7 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.4 | 1.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 0.4 | 5.3 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.4 | 1.9 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.4 | 1.5 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.4 | 7.5 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.4 | 1.9 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.4 | 3.0 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.4 | 7.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.4 | 1.1 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
| 0.4 | 0.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
| 0.4 | 2.6 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
| 0.4 | 1.5 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
| 0.4 | 1.1 | GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.4 | 1.8 | GO:1903906 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 0.4 | 1.5 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.4 | 1.8 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.4 | 0.7 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.4 | 1.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.4 | 1.4 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 0.4 | 0.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.4 | 2.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.4 | 1.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.4 | 2.5 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.4 | 7.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.4 | 1.8 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.4 | 1.8 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.4 | 0.7 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.4 | 1.8 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
| 0.4 | 1.4 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 0.4 | 3.5 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.4 | 1.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.4 | 1.4 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.4 | 1.4 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
| 0.4 | 1.8 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.3 | 1.7 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.3 | 1.0 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.3 | 1.4 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.3 | 2.1 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 0.3 | 3.8 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.3 | 0.3 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 0.3 | 2.1 | GO:1902957 | negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
| 0.3 | 1.4 | GO:1903204 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.3 | 2.4 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.3 | 0.7 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.3 | 0.7 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.3 | 1.0 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.3 | 2.7 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.3 | 0.3 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.3 | 1.7 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.3 | 6.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.3 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.3 | 3.3 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.3 | 2.9 | GO:0060174 | limb bud formation(GO:0060174) |
| 0.3 | 1.6 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.3 | 0.3 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
| 0.3 | 7.4 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.3 | 2.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.3 | 2.2 | GO:0008354 | germ cell migration(GO:0008354) |
| 0.3 | 1.9 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
| 0.3 | 1.9 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
| 0.3 | 0.3 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.3 | 1.3 | GO:0035627 | ceramide transport(GO:0035627) |
| 0.3 | 7.9 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.3 | 0.3 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.3 | 2.5 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 0.3 | 3.8 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.3 | 1.0 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.3 | 5.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.3 | 7.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.3 | 6.0 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.3 | 2.8 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.3 | 0.3 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.3 | 4.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.3 | 2.8 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.3 | 0.9 | GO:0003032 | detection of oxygen(GO:0003032) |
| 0.3 | 0.6 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
| 0.3 | 5.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.3 | 5.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.3 | 4.3 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
| 0.3 | 4.3 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.3 | 0.6 | GO:1905123 | negative regulation of protein catabolic process in the vacuole(GO:1904351) regulation of glucosylceramidase activity(GO:1905123) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.3 | 0.6 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.3 | 0.3 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 0.3 | 0.6 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 0.3 | 4.0 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.3 | 0.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.3 | 2.8 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.3 | 0.6 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.3 | 2.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
| 0.3 | 1.5 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.3 | 0.3 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.3 | 2.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.3 | 1.2 | GO:0046619 | optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
| 0.3 | 0.9 | GO:0097359 | UDP-glucosylation(GO:0097359) |
| 0.3 | 0.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.3 | 0.9 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.3 | 0.6 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.3 | 2.1 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.3 | 1.5 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.3 | 1.2 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
| 0.3 | 2.3 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.3 | 5.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.3 | 2.0 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.3 | 0.6 | GO:0050904 | diapedesis(GO:0050904) |
| 0.3 | 1.2 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.3 | 1.7 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.3 | 2.9 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.3 | 3.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.3 | 7.7 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
| 0.3 | 3.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.3 | 3.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.3 | 0.6 | GO:0002368 | B cell cytokine production(GO:0002368) |
| 0.3 | 6.5 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.3 | 3.7 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.3 | 3.1 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.3 | 0.8 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.3 | 2.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.3 | 2.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.3 | 3.1 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.3 | 5.9 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.3 | 1.4 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.3 | 1.4 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.3 | 0.3 | GO:0072720 | response to dithiothreitol(GO:0072720) |
| 0.3 | 2.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.3 | 0.6 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.3 | 2.5 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.3 | 4.1 | GO:0015871 | choline transport(GO:0015871) |
| 0.3 | 1.1 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.3 | 1.1 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.3 | 4.6 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.3 | 0.3 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 0.3 | 1.6 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.3 | 1.4 | GO:1904884 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.3 | 2.7 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.3 | 1.1 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.3 | 1.3 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.3 | 3.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.3 | 0.8 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.3 | 2.7 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.3 | 0.8 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 0.3 | 0.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.3 | 0.8 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.3 | 1.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.3 | 7.4 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.3 | 0.5 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.3 | 0.8 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.3 | 1.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.3 | 4.7 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.3 | 0.3 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
| 0.3 | 1.5 | GO:0042335 | cuticle development(GO:0042335) |
| 0.3 | 2.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.3 | 2.6 | GO:1990834 | response to odorant(GO:1990834) |
| 0.3 | 1.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.3 | 4.9 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.3 | 1.0 | GO:0046073 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
| 0.3 | 1.3 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.3 | 0.3 | GO:2000532 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
| 0.3 | 4.6 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.3 | 1.3 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 0.3 | 0.5 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.3 | 1.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.3 | 0.3 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.3 | 0.8 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
| 0.3 | 0.5 | GO:1900368 | regulation of RNA interference(GO:1900368) |
| 0.2 | 1.0 | GO:1902910 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of hair follicle maturation(GO:0048817) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 0.2 | 0.2 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
| 0.2 | 1.0 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.2 | 1.2 | GO:0061015 | snRNA import into nucleus(GO:0061015) |
| 0.2 | 0.2 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.2 | 0.7 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
| 0.2 | 2.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.2 | 2.0 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.2 | 1.7 | GO:0030953 | astral microtubule organization(GO:0030953) |
| 0.2 | 2.7 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 0.2 | 1.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.2 | 1.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.2 | 0.5 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.2 | 0.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.2 | 1.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.2 | 1.0 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
| 0.2 | 1.7 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.2 | 0.5 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.2 | 4.8 | GO:0016246 | RNA interference(GO:0016246) |
| 0.2 | 0.5 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
| 0.2 | 0.7 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.2 | 1.0 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.2 | 2.4 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.2 | 0.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 0.2 | 1.6 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.2 | 18.4 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
| 0.2 | 1.6 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.2 | 5.6 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
| 0.2 | 4.2 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.2 | 1.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.2 | 2.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.2 | 5.8 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.2 | 1.6 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.2 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.2 | 4.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.2 | 1.1 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.2 | 2.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.2 | 2.1 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.2 | 11.9 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.2 | 3.4 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.2 | 0.7 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
| 0.2 | 5.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.2 | 1.8 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.2 | 0.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 0.2 | 0.7 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
| 0.2 | 4.5 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
| 0.2 | 2.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.2 | 0.7 | GO:0060214 | endocardium formation(GO:0060214) |
| 0.2 | 0.7 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.2 | 0.7 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.2 | 3.4 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.2 | 0.4 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.2 | 1.1 | GO:2000690 | regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.2 | 1.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.2 | 1.3 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
| 0.2 | 2.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.2 | 0.9 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.2 | 2.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.2 | 0.9 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.2 | 0.4 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
| 0.2 | 0.9 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.2 | 0.7 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.2 | 4.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.2 | 1.3 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.2 | 2.6 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.2 | 1.9 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
| 0.2 | 2.6 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.2 | 3.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.2 | 0.2 | GO:0090151 | protein import into mitochondrial inner membrane(GO:0045039) establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 0.2 | 2.8 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.2 | 0.6 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.2 | 3.0 | GO:0015866 | ADP transport(GO:0015866) |
| 0.2 | 0.2 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.2 | 0.8 | GO:0060838 | radial pattern formation(GO:0009956) lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.2 | 0.4 | GO:1900180 | regulation of protein localization to nucleus(GO:1900180) |
| 0.2 | 9.3 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.2 | 3.6 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.2 | 1.3 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.2 | 0.4 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.2 | 2.5 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 0.2 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.2 | 1.5 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.2 | 1.0 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.2 | 0.8 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.2 | 0.8 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
| 0.2 | 2.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.2 | 1.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.2 | 2.2 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.2 | 0.6 | GO:0033488 | cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
| 0.2 | 1.4 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.2 | 2.8 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.2 | 1.0 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.2 | 1.0 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.2 | 1.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.2 | 0.6 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.2 | 0.6 | GO:0009078 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.2 | 6.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.2 | 0.8 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.2 | 0.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 | 0.2 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.2 | 1.2 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.2 | 0.6 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.2 | 14.6 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.2 | 1.2 | GO:0002353 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.2 | 1.2 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.2 | 0.6 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.2 | 1.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.2 | 7.2 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.2 | 1.6 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.2 | 1.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.2 | 3.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.2 | 4.6 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.2 | 0.6 | GO:0009597 | detection of virus(GO:0009597) |
| 0.2 | 2.5 | GO:0015074 | DNA integration(GO:0015074) |
| 0.2 | 1.0 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.2 | 11.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.2 | 0.6 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.2 | 2.5 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.2 | 12.9 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.2 | 2.7 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.2 | 4.3 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.2 | 0.9 | GO:0021622 | optic cup structural organization(GO:0003409) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.2 | 3.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.2 | 0.6 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
| 0.2 | 1.1 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.2 | 5.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.2 | 0.4 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 0.2 | 0.9 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 0.2 | 0.5 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.2 | 8.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.2 | 1.3 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.2 | 9.6 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.2 | 1.8 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 | 1.3 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.2 | 2.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.2 | 2.2 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.2 | 3.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
| 0.2 | 0.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.2 | 0.9 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.2 | 0.4 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) negative regulation of lamellipodium organization(GO:1902744) |
| 0.2 | 14.3 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
| 0.2 | 0.2 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.2 | 1.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.2 | 0.5 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
| 0.2 | 0.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.2 | 0.5 | GO:0061485 | memory T cell proliferation(GO:0061485) |
| 0.2 | 0.5 | GO:0070384 | Harderian gland development(GO:0070384) |
| 0.2 | 1.1 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.2 | 0.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.2 | 1.0 | GO:0015677 | copper ion import(GO:0015677) |
| 0.2 | 4.0 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.2 | 0.3 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.2 | 2.1 | GO:0016197 | endosomal transport(GO:0016197) |
| 0.2 | 0.3 | GO:0061724 | lipophagy(GO:0061724) |
| 0.2 | 2.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 | 0.9 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.2 | 0.7 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.2 | 1.6 | GO:0038127 | ERBB signaling pathway(GO:0038127) |
| 0.2 | 4.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 0.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.2 | 0.9 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.2 | 1.0 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.2 | 0.3 | GO:0097195 | pilomotor reflex(GO:0097195) |
| 0.2 | 0.7 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.2 | 0.7 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
| 0.2 | 2.0 | GO:0099630 | neurotransmitter receptor transport to plasma membrane(GO:0098877) neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) postsynaptic neurotransmitter receptor cycle(GO:0099630) protein localization to postsynaptic membrane(GO:1903539) establishment of protein localization to postsynaptic membrane(GO:1903540) |
| 0.2 | 0.2 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.2 | 0.3 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
| 0.2 | 0.5 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.2 | 0.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.2 | 0.5 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
| 0.2 | 1.0 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.2 | 1.5 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 0.2 | 0.7 | GO:0014870 | response to muscle inactivity(GO:0014870) |
| 0.2 | 0.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.2 | 0.2 | GO:2000779 | regulation of double-strand break repair(GO:2000779) |
| 0.2 | 2.8 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.2 | 2.0 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.2 | 18.7 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.2 | 9.8 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
| 0.2 | 12.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.2 | 2.1 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.2 | 0.5 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.2 | 1.3 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
| 0.2 | 1.0 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.2 | 5.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.2 | 0.8 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.2 | 0.6 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.2 | 1.0 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.2 | 0.5 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.2 | 1.3 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 0.2 | 0.3 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.2 | 0.3 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.2 | 0.6 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.2 | 1.0 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.2 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.2 | 0.3 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.2 | 4.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.2 | 1.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.2 | 0.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.2 | 2.4 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 0.2 | 2.8 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.2 | 3.8 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.2 | 0.3 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.2 | 0.2 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.2 | 0.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.2 | 0.8 | GO:1901093 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.2 | 0.5 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.2 | 3.4 | GO:0032526 | response to retinoic acid(GO:0032526) |
| 0.2 | 2.8 | GO:0015816 | glycine transport(GO:0015816) |
| 0.2 | 0.9 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.2 | 0.2 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
| 0.2 | 0.9 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.2 | 0.8 | GO:0072144 | glomerular mesangial cell development(GO:0072144) |
| 0.2 | 1.1 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 | 0.9 | GO:0018032 | protein amidation(GO:0018032) |
| 0.2 | 3.4 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
| 0.2 | 0.5 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.2 | 0.9 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
| 0.2 | 0.3 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
| 0.2 | 0.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.2 | 1.8 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.2 | 0.6 | GO:0060021 | palate development(GO:0060021) |
| 0.2 | 0.2 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
| 0.2 | 0.9 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.1 | 0.1 | GO:0040031 | snRNA pseudouridine synthesis(GO:0031120) snRNA modification(GO:0040031) |
| 0.1 | 0.1 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.1 | 1.8 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.1 | 1.6 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
| 0.1 | 1.8 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.1 | 3.4 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
| 0.1 | 0.4 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
| 0.1 | 1.0 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 0.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.1 | 2.0 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.1 | 0.9 | GO:0093001 | glycolytic process through glucose-1-phosphate(GO:0061622) glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.1 | 4.6 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.1 | 3.5 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.1 | 0.7 | GO:0030575 | nuclear body organization(GO:0030575) |
| 0.1 | 1.7 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.1 | 1.9 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
| 0.1 | 0.1 | GO:0072283 | renal vesicle morphogenesis(GO:0072077) renal vesicle development(GO:0072087) metanephric renal vesicle morphogenesis(GO:0072283) |
| 0.1 | 0.4 | GO:0070672 | response to interleukin-15(GO:0070672) |
| 0.1 | 0.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.1 | 1.1 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.1 | 7.6 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
| 0.1 | 1.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 0.1 | 1.0 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.1 | 1.1 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 0.1 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
| 0.1 | 2.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.1 | 0.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 | 0.3 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.1 | 1.2 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.1 | 2.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.1 | 2.5 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
| 0.1 | 0.4 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.1 | 0.5 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
| 0.1 | 0.5 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.1 | 0.8 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
| 0.1 | 0.3 | GO:0003091 | renal water homeostasis(GO:0003091) |
| 0.1 | 1.7 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
| 0.1 | 1.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.1 | 1.2 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.1 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.1 | 2.9 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 | 0.4 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.1 | 3.6 | GO:0042092 | type 2 immune response(GO:0042092) |
| 0.1 | 0.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.1 | 0.1 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
| 0.1 | 0.9 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.1 | 0.7 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.1 | 0.5 | GO:0019732 | antifungal humoral response(GO:0019732) |
| 0.1 | 0.5 | GO:0006218 | uridine catabolic process(GO:0006218) |
| 0.1 | 5.5 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.1 | 0.8 | GO:0030421 | defecation(GO:0030421) |
| 0.1 | 0.4 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.1 | 0.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.1 | 6.8 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
| 0.1 | 6.3 | GO:0035904 | aorta development(GO:0035904) |
| 0.1 | 0.5 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 | 0.1 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.1 | 0.5 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.1 | 2.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 | 0.4 | GO:0090042 | tubulin deacetylation(GO:0090042) |
| 0.1 | 2.8 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.1 | 0.9 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.1 | 0.8 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 0.1 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.1 | 0.5 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 | 0.9 | GO:0061436 | establishment of skin barrier(GO:0061436) |
| 0.1 | 0.6 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 | 3.7 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
| 0.1 | 3.6 | GO:1902593 | single-organism nuclear import(GO:1902593) |
| 0.1 | 0.6 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
| 0.1 | 1.0 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
| 0.1 | 0.2 | GO:0071625 | vocalization behavior(GO:0071625) |
| 0.1 | 1.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.1 | 1.2 | GO:0046599 | regulation of centriole replication(GO:0046599) |
| 0.1 | 1.0 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.1 | 7.0 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
| 0.1 | 4.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.1 | 0.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.1 | 0.1 | GO:0051653 | spindle localization(GO:0051653) |
| 0.1 | 3.2 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
| 0.1 | 1.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 0.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.1 | 0.9 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 | 0.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.1 | 0.5 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.1 | 0.1 | GO:0018307 | enzyme active site formation(GO:0018307) |
| 0.1 | 1.1 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.1 | 0.5 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.1 | 1.5 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.1 | 0.8 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
| 0.1 | 0.5 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 | 0.1 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) |
| 0.1 | 0.6 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.1 | 0.4 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.1 | 2.2 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.1 | 0.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.1 | 0.4 | GO:0071692 | sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.1 | 0.9 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
| 0.1 | 3.5 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 | 0.4 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.1 | 2.7 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
| 0.1 | 0.4 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 0.1 | 1.0 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.1 | 2.2 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.1 | 0.5 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) establishment of meiotic spindle localization(GO:0051295) formin-nucleated actin cable assembly(GO:0070649) |
| 0.1 | 2.7 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 0.1 | 0.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.1 | 0.9 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 | 0.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 1.0 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
| 0.1 | 0.5 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.1 | 0.9 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.1 | 0.4 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 | 0.5 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
| 0.1 | 0.2 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 0.1 | 0.8 | GO:1904587 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) response to glycoprotein(GO:1904587) |
| 0.1 | 0.6 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 | 1.3 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 | 3.3 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 | 0.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.1 | 0.9 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.1 | 2.7 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.1 | 0.4 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
| 0.1 | 0.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.1 | 1.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.1 | 0.2 | GO:0006405 | RNA export from nucleus(GO:0006405) |
| 0.1 | 0.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.1 | 1.6 | GO:0046051 | UTP metabolic process(GO:0046051) |
| 0.1 | 0.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.1 | 0.4 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 2.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.1 | 0.3 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.1 | 0.9 | GO:0044070 | regulation of anion transport(GO:0044070) |
| 0.1 | 1.0 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.1 | 0.8 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
| 0.1 | 1.3 | GO:0042554 | superoxide anion generation(GO:0042554) |
| 0.1 | 0.9 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 | 0.2 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.1 | 0.3 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 0.1 | 0.3 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
| 0.1 | 0.7 | GO:0071280 | cellular response to copper ion(GO:0071280) |
| 0.1 | 0.3 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.1 | 0.2 | GO:0060947 | endodermal cell fate determination(GO:0007493) cardiac vascular smooth muscle cell differentiation(GO:0060947) |
| 0.1 | 1.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 | 3.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.1 | 0.5 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
| 0.1 | 1.3 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.1 | 0.7 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
| 0.1 | 1.0 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of hormone biosynthetic process(GO:0032353) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
| 0.1 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 | 2.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.1 | 1.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.1 | 1.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.1 | 0.5 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.1 | 0.5 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 | 0.9 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.1 | 0.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.1 | 0.4 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
| 0.1 | 0.8 | GO:0030837 | negative regulation of actin filament polymerization(GO:0030837) |
| 0.1 | 0.9 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.1 | 0.2 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
| 0.1 | 0.3 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
| 0.1 | 0.5 | GO:1902722 | gamma-aminobutyric acid catabolic process(GO:0009450) negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) positive regulation of prolactin secretion(GO:1902722) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.1 | 0.5 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.1 | 0.3 | GO:0036507 | protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) |
| 0.1 | 0.5 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 | 0.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 | 1.0 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 | 0.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.1 | 0.7 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 | 1.6 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
| 0.1 | 0.3 | GO:0033319 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.1 | 0.2 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
| 0.1 | 0.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 0.1 | 0.5 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
| 0.1 | 1.1 | GO:0000717 | nucleotide-excision repair, DNA duplex unwinding(GO:0000717) |
| 0.1 | 0.6 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.1 | 0.3 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
| 0.1 | 0.6 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.1 | 2.8 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.1 | 0.4 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.1 | 2.2 | GO:0043542 | endothelial cell migration(GO:0043542) |
| 0.1 | 0.3 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 0.1 | 0.2 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.1 | 0.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 | 0.3 | GO:0038145 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.1 | 3.3 | GO:0097484 | dendrite extension(GO:0097484) |
| 0.1 | 0.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.1 | 2.3 | GO:0090659 | walking behavior(GO:0090659) |
| 0.1 | 0.3 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.1 | 1.9 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 0.1 | 0.3 | GO:0018277 | protein deamination(GO:0018277) |
| 0.1 | 0.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 | 4.6 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
| 0.1 | 0.2 | GO:1903998 | regulation of eating behavior(GO:1903998) |
| 0.1 | 0.4 | GO:0031016 | pancreas development(GO:0031016) |
| 0.1 | 2.0 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.1 | 1.5 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
| 0.1 | 0.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.1 | 0.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.1 | 0.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 | 0.4 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 | 2.2 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.1 | 1.6 | GO:1902591 | single-organism membrane budding(GO:1902591) |
| 0.1 | 0.1 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.1 | 0.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 | 3.5 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
| 0.1 | 0.1 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) regulation of extrathymic T cell differentiation(GO:0033082) |
| 0.1 | 0.4 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.1 | 5.3 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
| 0.1 | 1.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.1 | 0.8 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.1 | 0.2 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.1 | 6.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.1 | 0.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.1 | 0.5 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.1 | 0.7 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.1 | 0.4 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 | 0.4 | GO:0015862 | uridine transport(GO:0015862) |
| 0.1 | 2.2 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 | 0.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.1 | 1.1 | GO:0060004 | reflex(GO:0060004) |
| 0.1 | 0.8 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
| 0.1 | 0.5 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.1 | 0.9 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.1 | 0.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.1 | 0.9 | GO:0007379 | segment specification(GO:0007379) |
| 0.1 | 0.4 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.1 | 0.4 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.1 | 0.3 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.1 | 0.3 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
| 0.1 | 0.1 | GO:0046102 | inosine metabolic process(GO:0046102) |
| 0.1 | 2.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.1 | 0.1 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.1 | 0.4 | GO:0015740 | C4-dicarboxylate transport(GO:0015740) succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.1 | 1.8 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
| 0.1 | 0.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 | 2.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.1 | 0.3 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 | 1.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.1 | 0.3 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.1 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.1 | 0.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 0.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 0.1 | 0.3 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.1 | 0.7 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.1 | 0.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 | 0.3 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.1 | 0.1 | GO:0051602 | response to electrical stimulus(GO:0051602) |
| 0.1 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 | 0.2 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 | 0.3 | GO:0031455 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.1 | 0.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.1 | 1.2 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
| 0.1 | 0.3 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.1 | 0.1 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.1 | 0.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.1 | 1.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.1 | 0.7 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
| 0.1 | 0.4 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 0.1 | 0.7 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
| 0.1 | 0.1 | GO:0042439 | ethanolamine-containing compound metabolic process(GO:0042439) |
| 0.1 | 1.4 | GO:0007030 | Golgi organization(GO:0007030) |
| 0.1 | 0.6 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.1 | 0.3 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.1 | 0.2 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
| 0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 | 0.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.1 | 0.3 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.1 | 0.3 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.1 | 0.6 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
| 0.1 | 0.8 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 | 0.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
| 0.1 | 0.2 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
| 0.1 | 0.2 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.1 | 0.2 | GO:0009407 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.1 | 0.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 | 0.4 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.1 | 0.1 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 0.1 | 0.2 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
| 0.1 | 0.7 | GO:0000266 | mitochondrial fission(GO:0000266) |
| 0.1 | 0.4 | GO:0060347 | heart trabecula formation(GO:0060347) |
| 0.1 | 2.3 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.1 | 1.1 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
| 0.1 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.1 | 0.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.1 | 0.5 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.1 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
| 0.1 | 0.2 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.1 | 0.3 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 | 0.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 | 7.8 | GO:0051028 | mRNA transport(GO:0051028) |
| 0.1 | 1.2 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.1 | 0.6 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
| 0.1 | 0.2 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
| 0.1 | 0.2 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.1 | 0.1 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 0.1 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
| 0.1 | 1.3 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
| 0.1 | 1.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 | 0.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.1 | 3.1 | GO:0051168 | nuclear export(GO:0051168) |
| 0.1 | 0.7 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
| 0.1 | 0.4 | GO:0006999 | nuclear pore organization(GO:0006999) |
| 0.1 | 0.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.1 | 2.3 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.1 | 0.2 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) ERK5 cascade(GO:0070375) |
| 0.1 | 0.9 | GO:0031498 | chromatin disassembly(GO:0031498) |
| 0.1 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.1 | 1.1 | GO:0050678 | regulation of epithelial cell proliferation(GO:0050678) |
| 0.1 | 0.1 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) |
| 0.1 | 0.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.1 | 0.1 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.1 | 0.1 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.1 | 1.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.1 | 1.0 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.1 | 1.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.1 | 0.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.1 | 0.1 | GO:0019474 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.1 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
| 0.1 | 1.5 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.1 | 1.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.1 | 1.9 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.1 | 0.9 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 | 0.1 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
| 0.1 | 2.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.1 | 1.0 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 | 0.5 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.0 | 0.2 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.0 | 0.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 | 1.3 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation(GO:0050731) |
| 0.0 | 0.1 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.0 | 4.7 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
| 0.0 | 0.2 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.0 | 2.2 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
| 0.0 | 0.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.0 | 0.1 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.0 | 1.7 | GO:0008038 | neuron recognition(GO:0008038) |
| 0.0 | 0.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.0 | 1.7 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
| 0.0 | 0.3 | GO:0097205 | renal filtration(GO:0097205) |
| 0.0 | 0.2 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
| 0.0 | 0.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 | 4.8 | GO:0006821 | chloride transport(GO:0006821) |
| 0.0 | 0.1 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.0 | 0.4 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.0 | 0.1 | GO:0072757 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
| 0.0 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.0 | 1.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.0 | 0.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 | 0.1 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.0 | 0.2 | GO:0060424 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
| 0.0 | 0.2 | GO:1902686 | positive regulation of mitochondrial membrane permeability(GO:0035794) positive regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902110) mitochondrial outer membrane permeabilization involved in programmed cell death(GO:1902686) |
| 0.0 | 1.8 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.0 | 1.1 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.0 | 0.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.0 | 0.6 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.0 | 0.3 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
| 0.0 | 0.1 | GO:0072164 | ureteric bud development(GO:0001657) mesonephric epithelium development(GO:0072163) mesonephric tubule development(GO:0072164) |
| 0.0 | 0.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.0 | 1.1 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.0 | 0.5 | GO:1903543 | positive regulation of exosomal secretion(GO:1903543) |
| 0.0 | 0.3 | GO:0030316 | osteoclast differentiation(GO:0030316) |
| 0.0 | 1.7 | GO:0046037 | GMP metabolic process(GO:0046037) |
| 0.0 | 0.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 | 0.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.0 | 0.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 0.0 | 0.2 | GO:0010288 | response to lead ion(GO:0010288) |
| 0.0 | 0.9 | GO:0007616 | long-term memory(GO:0007616) |
| 0.0 | 0.3 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
| 0.0 | 0.5 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.0 | 1.3 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.0 | 0.1 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 0.0 | 4.9 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.0 | 0.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.0 | 0.4 | GO:0051255 | spindle midzone assembly(GO:0051255) |
| 0.0 | 0.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
| 0.0 | 0.1 | GO:0007099 | centriole replication(GO:0007099) |
| 0.0 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.0 | 0.0 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
| 0.0 | 0.8 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.0 | 0.3 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
| 0.0 | 0.2 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.0 | 0.3 | GO:0072189 | ureter development(GO:0072189) |
| 0.0 | 0.4 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.0 | 2.6 | GO:0021987 | cerebral cortex development(GO:0021987) |
| 0.0 | 0.1 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
| 0.0 | 2.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.0 | 0.7 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
| 0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
| 0.0 | 2.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 | 0.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.0 | 0.1 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 0.0 | 0.2 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.0 | 0.1 | GO:2000672 | regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.0 | 0.2 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.0 | 2.1 | GO:0001895 | retina homeostasis(GO:0001895) |
| 0.0 | 0.1 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.0 | 2.3 | GO:0014032 | neural crest cell development(GO:0014032) |
| 0.0 | 0.1 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.0 | 0.4 | GO:0031529 | ruffle organization(GO:0031529) |
| 0.0 | 0.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 | 0.9 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.0 | 0.4 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.0 | 0.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.0 | 0.2 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.0 | 1.3 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
| 0.0 | 0.1 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.0 | 0.3 | GO:0051169 | nuclear transport(GO:0051169) |
| 0.0 | 1.7 | GO:0001764 | neuron migration(GO:0001764) |
| 0.0 | 0.0 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
| 0.0 | 0.8 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.0 | 0.2 | GO:1903286 | regulation of potassium ion import(GO:1903286) |
| 0.0 | 0.2 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
| 0.0 | 0.3 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.0 | 3.1 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.0 | 0.4 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
| 0.0 | 0.1 | GO:0010157 | response to chlorate(GO:0010157) |
| 0.0 | 0.1 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 | 0.6 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
| 0.0 | 0.1 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.0 | 0.2 | GO:0048659 | smooth muscle cell proliferation(GO:0048659) |
| 0.0 | 0.1 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.0 | 0.5 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.0 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
| 0.0 | 0.5 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.0 | 0.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.0 | 0.2 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.0 | 1.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.0 | 0.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
| 0.0 | 0.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.0 | 0.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 | 0.1 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 0.0 | 0.3 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.0 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
| 0.0 | 0.4 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.0 | 0.7 | GO:0007340 | acrosome reaction(GO:0007340) |
| 0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 | 0.1 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
| 0.0 | 0.0 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 0.0 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.0 | 0.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 0.0 | 0.4 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
| 0.0 | 0.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.0 | 0.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.0 | 0.1 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
| 0.0 | 0.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.0 | 0.5 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.0 | 0.7 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
| 0.0 | 0.1 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.0 | 0.8 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 | 0.3 | GO:0070670 | response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
| 0.0 | 0.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.0 | 0.3 | GO:0006836 | neurotransmitter transport(GO:0006836) |
| 0.0 | 0.0 | GO:1903980 | positive regulation of microglial cell activation(GO:1903980) |
| 0.0 | 0.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.0 | 0.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
| 0.0 | 0.1 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
| 0.0 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 0.0 | 0.4 | GO:0046785 | microtubule polymerization(GO:0046785) |
| 0.0 | 0.1 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 0.0 | 0.2 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 | 0.1 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.0 | 0.1 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.0 | 0.4 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
| 0.0 | 0.3 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.0 | 0.1 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
| 0.0 | 0.1 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
| 0.0 | 0.7 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.0 | 0.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.0 | 0.6 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.0 | 0.6 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.0 | 0.1 | GO:0034397 | telomere localization(GO:0034397) |
| 0.0 | 0.1 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.0 | 0.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.0 | 0.2 | GO:0032801 | receptor catabolic process(GO:0032801) |
| 0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 0.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.0 | 0.3 | GO:0097352 | autophagosome maturation(GO:0097352) |
| 0.0 | 0.9 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.0 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.0 | 0.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 | 0.1 | GO:0043254 | regulation of protein complex assembly(GO:0043254) |
| 0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.0 | 2.1 | GO:0000910 | cytokinesis(GO:0000910) |
| 0.0 | 0.2 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.0 | 0.7 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.0 | 0.1 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.0 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 | 0.1 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.0 | 0.1 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.0 | 0.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 0.0 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.0 | 0.7 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 | 0.2 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.0 | 0.2 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 0.0 | 0.8 | GO:0019985 | translesion synthesis(GO:0019985) |
| 0.0 | 0.1 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.0 | 0.1 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.0 | 0.1 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 0.0 | 0.0 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.0 | 0.5 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
| 0.0 | 0.1 | GO:0014812 | muscle cell migration(GO:0014812) |
| 0.0 | 0.0 | GO:0071674 | mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
| 0.0 | 0.3 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 | 0.0 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.0 | 0.1 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.0 | 0.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.0 | 0.0 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
| 0.0 | 1.0 | GO:0003341 | cilium movement(GO:0003341) |
| 0.0 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 0.0 | 0.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 | 0.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
| 0.0 | 0.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.0 | 0.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.0 | 0.1 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
| 0.0 | 0.1 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
| 0.0 | 0.4 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
| 0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.0 | 0.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.0 | 0.0 | GO:0035900 | response to isolation stress(GO:0035900) |
| 0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
| 0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.0 | 0.0 | GO:0061055 | myotome development(GO:0061055) |
| 0.0 | 0.0 | GO:0022616 | DNA strand elongation involved in DNA replication(GO:0006271) DNA strand elongation(GO:0022616) |
| 0.0 | 0.4 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
| 0.0 | 0.2 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
| 0.0 | 0.0 | GO:0032679 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.0 | 0.0 | GO:0060349 | bone morphogenesis(GO:0060349) |
| 0.0 | 0.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 | 0.1 | GO:0060976 | coronary vasculature development(GO:0060976) |
| 0.0 | 0.3 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.0 | 0.1 | GO:0007614 | short-term memory(GO:0007614) |
| 0.0 | 0.0 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
| 0.0 | 0.1 | GO:0030307 | positive regulation of cell growth(GO:0030307) |
| 0.0 | 0.4 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 | 0.1 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
| 0.0 | 0.1 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.0 | 0.1 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.0 | 0.0 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
| 0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
| 0.0 | 0.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 | 0.3 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.1 | 6.3 | GO:0032783 | ELL-EAF complex(GO:0032783) |
| 1.8 | 7.1 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
| 1.6 | 9.9 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 1.6 | 6.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 1.6 | 19.3 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 1.6 | 3.1 | GO:0097227 | sperm annulus(GO:0097227) |
| 1.6 | 7.8 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 1.5 | 4.6 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
| 1.5 | 15.0 | GO:0033503 | HULC complex(GO:0033503) |
| 1.5 | 17.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 1.4 | 4.2 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 1.4 | 8.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 1.4 | 5.5 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 1.3 | 5.3 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 1.3 | 8.0 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
| 1.3 | 9.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 1.2 | 7.4 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 1.2 | 3.6 | GO:0018444 | translation release factor complex(GO:0018444) |
| 1.2 | 2.3 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 1.2 | 4.6 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
| 1.1 | 3.4 | GO:0005745 | m-AAA complex(GO:0005745) |
| 1.1 | 4.5 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 1.0 | 4.1 | GO:1990745 | EARP complex(GO:1990745) |
| 1.0 | 4.0 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 1.0 | 3.8 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
| 0.9 | 7.4 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.9 | 1.9 | GO:0089701 | U2AF(GO:0089701) |
| 0.9 | 2.7 | GO:0009346 | citrate lyase complex(GO:0009346) |
| 0.9 | 10.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.9 | 2.6 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.8 | 3.3 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.8 | 3.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.8 | 3.2 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 0.8 | 2.4 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
| 0.8 | 2.4 | GO:0044393 | microspike(GO:0044393) |
| 0.8 | 18.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.8 | 10.9 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.8 | 13.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.8 | 4.5 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 0.8 | 3.8 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.7 | 2.9 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 0.7 | 5.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.7 | 2.9 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.7 | 7.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.7 | 1.4 | GO:0043614 | multi-eIF complex(GO:0043614) |
| 0.7 | 4.9 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.7 | 2.7 | GO:0070985 | TFIIK complex(GO:0070985) |
| 0.7 | 1.4 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 0.7 | 5.4 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.7 | 4.0 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.7 | 2.0 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.7 | 2.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.6 | 1.9 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
| 0.6 | 7.0 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.6 | 3.8 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.6 | 1.9 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
| 0.6 | 3.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.6 | 6.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.6 | 11.9 | GO:0090543 | Flemming body(GO:0090543) |
| 0.6 | 7.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.6 | 2.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.6 | 8.8 | GO:0030478 | actin cap(GO:0030478) |
| 0.6 | 22.3 | GO:0031105 | septin complex(GO:0031105) |
| 0.6 | 5.8 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.6 | 2.9 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.6 | 2.3 | GO:0005607 | laminin-2 complex(GO:0005607) |
| 0.6 | 1.1 | GO:0055087 | Ski complex(GO:0055087) |
| 0.6 | 2.3 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.6 | 1.7 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.6 | 14.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.6 | 2.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.5 | 1.1 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.5 | 3.8 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.5 | 2.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.5 | 1.6 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.5 | 1.1 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
| 0.5 | 1.6 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.5 | 0.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.5 | 5.1 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.5 | 6.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.5 | 6.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.5 | 2.5 | GO:0035838 | growing cell tip(GO:0035838) |
| 0.5 | 13.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.5 | 3.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.5 | 2.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.5 | 1.5 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 0.5 | 2.4 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
| 0.5 | 1.5 | GO:0097441 | basilar dendrite(GO:0097441) |
| 0.5 | 4.7 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.5 | 4.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.5 | 5.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.5 | 4.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.5 | 2.3 | GO:0031417 | NatC complex(GO:0031417) |
| 0.5 | 3.6 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.5 | 3.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.4 | 2.2 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
| 0.4 | 2.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.4 | 0.9 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.4 | 8.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.4 | 3.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.4 | 2.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.4 | 4.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.4 | 5.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.4 | 6.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.4 | 4.3 | GO:0005675 | holo TFIIH complex(GO:0005675) |
| 0.4 | 4.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.4 | 9.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.4 | 2.8 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.4 | 2.8 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.4 | 2.4 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.4 | 1.2 | GO:0005595 | collagen type XII trimer(GO:0005595) |
| 0.4 | 2.8 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.4 | 1.5 | GO:0031592 | centrosomal corona(GO:0031592) |
| 0.4 | 4.1 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.4 | 1.1 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
| 0.4 | 1.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.4 | 1.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.4 | 1.1 | GO:0001534 | radial spoke(GO:0001534) |
| 0.4 | 4.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.4 | 11.5 | GO:0071437 | invadopodium(GO:0071437) |
| 0.4 | 2.1 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 0.4 | 2.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.4 | 13.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.4 | 1.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.4 | 1.8 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.3 | 3.5 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
| 0.3 | 2.8 | GO:0005844 | polysome(GO:0005844) |
| 0.3 | 1.7 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 0.3 | 2.1 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.3 | 1.0 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.3 | 5.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.3 | 10.8 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.3 | 2.7 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.3 | 1.0 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.3 | 0.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.3 | 1.7 | GO:0071942 | XPC complex(GO:0071942) |
| 0.3 | 1.6 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
| 0.3 | 22.0 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.3 | 1.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.3 | 1.9 | GO:0031673 | H zone(GO:0031673) |
| 0.3 | 5.1 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.3 | 1.6 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.3 | 4.1 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.3 | 40.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.3 | 1.2 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.3 | 0.9 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.3 | 10.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.3 | 0.3 | GO:0030689 | Noc complex(GO:0030689) |
| 0.3 | 5.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.3 | 1.5 | GO:0016342 | catenin complex(GO:0016342) |
| 0.3 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.3 | 1.2 | GO:0045179 | apical cortex(GO:0045179) |
| 0.3 | 2.0 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.3 | 3.5 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.3 | 1.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.3 | 0.6 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.3 | 2.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.3 | 1.4 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.3 | 3.4 | GO:0030057 | desmosome(GO:0030057) |
| 0.3 | 1.9 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.3 | 7.1 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.3 | 0.5 | GO:0071203 | WASH complex(GO:0071203) |
| 0.3 | 6.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.3 | 1.6 | GO:0044308 | axonal spine(GO:0044308) |
| 0.3 | 7.7 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.3 | 0.5 | GO:0051286 | cell tip(GO:0051286) |
| 0.3 | 11.8 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.3 | 4.4 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.3 | 1.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.3 | 5.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.3 | 0.5 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
| 0.3 | 3.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.2 | 4.0 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.2 | 1.2 | GO:0097179 | protease inhibitor complex(GO:0097179) |
| 0.2 | 1.7 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.2 | 11.9 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.2 | 14.9 | GO:0002102 | podosome(GO:0002102) |
| 0.2 | 5.5 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.2 | 1.9 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.2 | 8.3 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.2 | 0.9 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.2 | 1.4 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.2 | 1.6 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.2 | 1.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.2 | 3.5 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.2 | 1.6 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.2 | 2.1 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.2 | 1.1 | GO:0032449 | CBM complex(GO:0032449) |
| 0.2 | 4.3 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.2 | 0.7 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.2 | 3.3 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.2 | 27.1 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.2 | 1.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.2 | 4.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.2 | 6.1 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.2 | 5.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.2 | 0.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.2 | 5.6 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.2 | 2.4 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.2 | 3.6 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.2 | 4.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.2 | 6.8 | GO:0030904 | retromer complex(GO:0030904) |
| 0.2 | 1.1 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.2 | 0.8 | GO:0098536 | deuterosome(GO:0098536) |
| 0.2 | 6.4 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.2 | 9.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 0.2 | 12.3 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.2 | 6.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.2 | 1.4 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.2 | 0.2 | GO:0036019 | endolysosome(GO:0036019) |
| 0.2 | 0.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.2 | 32.9 | GO:0016605 | PML body(GO:0016605) |
| 0.2 | 1.0 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.2 | 0.6 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.2 | 4.7 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.2 | 2.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.2 | 18.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.2 | 1.9 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.2 | 1.5 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.2 | 0.4 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.2 | 0.8 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.2 | 1.3 | GO:0000243 | commitment complex(GO:0000243) |
| 0.2 | 2.3 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.2 | 7.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.2 | 4.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.2 | 8.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.2 | 1.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.2 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.2 | 2.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.2 | 0.4 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.2 | 3.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.2 | 0.4 | GO:0000806 | Y chromosome(GO:0000806) |
| 0.2 | 2.6 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.2 | 2.5 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.2 | 1.6 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.2 | 1.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.2 | 0.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.2 | 18.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.2 | 0.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.2 | 18.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.2 | 2.8 | GO:0043203 | axon hillock(GO:0043203) |
| 0.2 | 5.4 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.2 | 1.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.2 | 1.5 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.2 | 2.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.2 | 5.2 | GO:0000145 | exocyst(GO:0000145) |
| 0.2 | 4.7 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.2 | 1.2 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.2 | 2.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.2 | 3.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.2 | 0.7 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 0.2 | 1.0 | GO:0010369 | chromocenter(GO:0010369) |
| 0.2 | 0.5 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.2 | 4.2 | GO:0030684 | preribosome(GO:0030684) |
| 0.2 | 4.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.2 | 0.5 | GO:1990462 | omegasome(GO:1990462) |
| 0.2 | 0.8 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.2 | 85.0 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.2 | 7.4 | GO:0015030 | Cajal body(GO:0015030) |
| 0.2 | 1.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.2 | 0.5 | GO:0008623 | CHRAC(GO:0008623) |
| 0.2 | 0.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.2 | 0.6 | GO:0035770 | ribonucleoprotein granule(GO:0035770) |
| 0.2 | 0.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 0.2 | 4.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.2 | 0.6 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
| 0.2 | 1.8 | GO:0030120 | vesicle coat(GO:0030120) |
| 0.2 | 0.9 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.2 | 0.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.1 | 0.7 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.1 | 0.6 | GO:0031523 | Myb complex(GO:0031523) |
| 0.1 | 4.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.1 | 0.6 | GO:0005694 | chromosome(GO:0005694) |
| 0.1 | 1.0 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
| 0.1 | 1.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.1 | 1.3 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.1 | 0.3 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.1 | 1.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.1 | 25.6 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 0.1 | 2.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.1 | 1.9 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.1 | 0.4 | GO:0000796 | condensin complex(GO:0000796) |
| 0.1 | 4.4 | GO:0038201 | TOR complex(GO:0038201) |
| 0.1 | 9.2 | GO:0045095 | keratin filament(GO:0045095) |
| 0.1 | 0.4 | GO:1990393 | 3M complex(GO:1990393) |
| 0.1 | 0.8 | GO:0043219 | lateral loop(GO:0043219) |
| 0.1 | 1.9 | GO:0097433 | dense body(GO:0097433) |
| 0.1 | 5.2 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.1 | 7.9 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.1 | 1.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.1 | 2.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.1 | 0.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.1 | 5.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.1 | 1.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.1 | 0.5 | GO:0030891 | VCB complex(GO:0030891) |
| 0.1 | 0.4 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 0.1 | 1.1 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.1 | 3.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.1 | 1.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.1 | 0.9 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.1 | 2.5 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 2.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.1 | 1.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.1 | 2.2 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.1 | 4.1 | GO:0005921 | gap junction(GO:0005921) |
| 0.1 | 0.3 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.1 | 2.2 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.1 | 0.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.1 | 19.3 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.1 | 0.3 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.1 | 0.7 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.1 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.1 | 2.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
| 0.1 | 0.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.1 | 2.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.1 | 7.3 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.1 | 0.9 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
| 0.1 | 1.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.1 | 0.8 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.1 | 2.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.1 | 0.6 | GO:0001740 | Barr body(GO:0001740) |
| 0.1 | 0.4 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.1 | 0.8 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.1 | 3.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.1 | 0.5 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.1 | 0.7 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.1 | 0.1 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 0.1 | 0.6 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 12.9 | GO:0000922 | spindle pole(GO:0000922) |
| 0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 3.1 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.1 | 9.2 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 12.8 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.1 | 0.4 | GO:1990812 | growth cone filopodium(GO:1990812) |
| 0.1 | 0.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.1 | 1.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.1 | 5.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 0.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.1 | 0.8 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.1 | 0.2 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.1 | 1.5 | GO:0005901 | caveola(GO:0005901) |
| 0.1 | 1.0 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.1 | 0.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.1 | 0.8 | GO:0044754 | autolysosome(GO:0044754) |
| 0.1 | 5.8 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.1 | 0.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 0.6 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.1 | 0.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.1 | 4.3 | GO:0005903 | brush border(GO:0005903) |
| 0.1 | 0.2 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.1 | 2.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.1 | 0.8 | GO:0099568 | cytoplasmic region(GO:0099568) |
| 0.1 | 0.6 | GO:0031045 | dense core granule(GO:0031045) |
| 0.1 | 0.5 | GO:0070187 | telosome(GO:0070187) |
| 0.1 | 6.6 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.1 | 0.7 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.1 | 0.9 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.1 | 16.2 | GO:0005911 | cell-cell junction(GO:0005911) |
| 0.1 | 0.6 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.1 | 0.5 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.1 | 6.4 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.1 | 0.2 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.1 | 0.7 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.1 | 5.8 | GO:0005884 | actin filament(GO:0005884) |
| 0.1 | 3.4 | GO:0000786 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
| 0.1 | 2.0 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 0.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.1 | 0.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.1 | 0.3 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.1 | 12.9 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.1 | 3.2 | GO:0030054 | cell junction(GO:0030054) |
| 0.1 | 1.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.1 | 6.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.1 | 1.5 | GO:0032420 | stereocilium(GO:0032420) |
| 0.1 | 20.0 | GO:0015629 | actin cytoskeleton(GO:0015629) |
| 0.1 | 1.4 | GO:0030315 | T-tubule(GO:0030315) |
| 0.1 | 2.2 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 0.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 15.1 | GO:0016604 | nuclear body(GO:0016604) |
| 0.1 | 0.4 | GO:0097386 | glial cell projection(GO:0097386) |
| 0.1 | 0.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.0 | 6.3 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.0 | 0.3 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.0 | 4.6 | GO:0030018 | Z disc(GO:0030018) |
| 0.0 | 0.3 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.0 | 0.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.0 | 0.2 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.0 | 2.5 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.0 | 0.2 | GO:0042627 | chylomicron(GO:0042627) |
| 0.0 | 0.4 | GO:0036126 | sperm flagellum(GO:0036126) |
| 0.0 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.0 | 2.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 0.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.0 | 1.5 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.0 | 0.4 | GO:0072487 | MSL complex(GO:0072487) |
| 0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.0 | 0.1 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.0 | 0.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.0 | 0.6 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.0 | 0.3 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.0 | 0.3 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.0 | 0.1 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.0 | 0.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.0 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.0 | 1.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.0 | 0.1 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 3.7 | GO:0001726 | ruffle(GO:0001726) |
| 0.0 | 0.4 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.0 | 4.1 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.0 | 0.4 | GO:0036038 | MKS complex(GO:0036038) |
| 0.0 | 0.1 | GO:0030135 | coated vesicle(GO:0030135) |
| 0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.0 | 0.3 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.0 | 0.9 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.0 | 0.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.0 | 0.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.0 | 0.3 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.0 | 0.3 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.0 | 0.2 | GO:0042581 | specific granule(GO:0042581) |
| 0.0 | 1.0 | GO:0019867 | outer membrane(GO:0019867) |
| 0.0 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.0 | 0.8 | GO:0031252 | cell leading edge(GO:0031252) |
| 0.0 | 0.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.0 | 2.4 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 0.0 | 0.9 | GO:0031253 | cell projection membrane(GO:0031253) |
| 0.0 | 1.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 1.1 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.0 | 0.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.0 | 0.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.0 | 0.2 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.0 | 1.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.0 | 0.2 | GO:0034399 | nuclear periphery(GO:0034399) |
| 0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.0 | 0.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.0 | 0.1 | GO:0019012 | virion(GO:0019012) virion part(GO:0044423) |
| 0.0 | 5.8 | GO:0044440 | endosomal part(GO:0044440) |
| 0.0 | 0.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.0 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 0.0 | 0.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.0 | 0.2 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
| 0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.0 | 0.1 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.0 | 0.1 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
| 0.0 | 0.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 0.6 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.0 | 0.0 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.0 | 0.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.0 | 0.0 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.0 | 3.0 | GO:0005768 | endosome(GO:0005768) |
| 0.0 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.3 | 6.8 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 1.8 | 7.1 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
| 1.5 | 4.6 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
| 1.5 | 10.5 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 1.5 | 5.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 1.5 | 29.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 1.4 | 4.2 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
| 1.3 | 8.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 1.3 | 5.1 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 1.3 | 5.0 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 1.2 | 4.9 | GO:1990175 | EH domain binding(GO:1990175) |
| 1.2 | 3.7 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
| 1.2 | 4.9 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 1.2 | 5.8 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 1.2 | 4.6 | GO:0004644 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) |
| 1.1 | 4.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 1.1 | 4.6 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 1.1 | 3.3 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 1.1 | 9.6 | GO:0032450 | alpha-1,4-glucosidase activity(GO:0004558) maltose alpha-glucosidase activity(GO:0032450) |
| 1.1 | 3.2 | GO:0016768 | spermine synthase activity(GO:0016768) |
| 1.0 | 8.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 1.0 | 5.9 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 1.0 | 2.9 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
| 1.0 | 4.9 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 1.0 | 2.9 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 1.0 | 11.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.9 | 3.8 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.9 | 13.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.9 | 5.6 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.9 | 2.7 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.9 | 7.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.9 | 2.7 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.9 | 9.7 | GO:0050544 | arachidonic acid binding(GO:0050544) |
| 0.9 | 3.5 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.9 | 3.5 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
| 0.9 | 4.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.8 | 3.4 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
| 0.8 | 4.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.8 | 7.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.8 | 3.1 | GO:0004663 | protein geranylgeranyltransferase activity(GO:0004661) Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.8 | 3.8 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.8 | 2.3 | GO:0019961 | interferon binding(GO:0019961) |
| 0.8 | 4.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.8 | 6.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.8 | 18.2 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.8 | 2.3 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 0.8 | 3.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.7 | 2.9 | GO:0035501 | MH1 domain binding(GO:0035501) |
| 0.7 | 2.9 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.7 | 5.8 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.7 | 5.0 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.7 | 5.0 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.7 | 4.8 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.7 | 2.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.7 | 2.1 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
| 0.7 | 5.5 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.7 | 2.1 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
| 0.7 | 3.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.7 | 5.4 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.7 | 2.7 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.7 | 2.7 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 0.7 | 5.4 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.7 | 0.7 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
| 0.6 | 1.9 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 0.6 | 5.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.6 | 2.5 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 0.6 | 2.5 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
| 0.6 | 3.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.6 | 3.7 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
| 0.6 | 5.6 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.6 | 1.8 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.6 | 6.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
| 0.6 | 3.0 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.6 | 1.8 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 0.6 | 1.8 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.6 | 3.6 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 0.6 | 1.8 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
| 0.6 | 1.8 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 0.6 | 6.5 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.6 | 2.9 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
| 0.6 | 2.9 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
| 0.6 | 12.8 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.6 | 1.7 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.6 | 2.9 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
| 0.5 | 2.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.5 | 1.6 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
| 0.5 | 2.2 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
| 0.5 | 3.2 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 0.5 | 2.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.5 | 3.2 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.5 | 2.6 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.5 | 1.5 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.5 | 4.6 | GO:0071253 | connexin binding(GO:0071253) |
| 0.5 | 1.5 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 0.5 | 1.0 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.5 | 7.0 | GO:0089720 | caspase binding(GO:0089720) |
| 0.5 | 3.0 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.5 | 1.0 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
| 0.5 | 6.5 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.5 | 3.0 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.5 | 1.5 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
| 0.5 | 1.5 | GO:0002113 | interleukin-33 binding(GO:0002113) |
| 0.5 | 2.9 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.5 | 1.4 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.5 | 2.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.5 | 4.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.5 | 0.5 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.5 | 1.9 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.5 | 2.8 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.5 | 1.4 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.5 | 1.8 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
| 0.5 | 9.0 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
| 0.4 | 3.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.4 | 3.1 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
| 0.4 | 2.7 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.4 | 9.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.4 | 13.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.4 | 24.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.4 | 2.2 | GO:0031403 | lithium ion binding(GO:0031403) |
| 0.4 | 6.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.4 | 10.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.4 | 2.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.4 | 1.3 | GO:0001003 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
| 0.4 | 1.3 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.4 | 2.2 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.4 | 1.7 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
| 0.4 | 5.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.4 | 0.4 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.4 | 3.0 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.4 | 2.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.4 | 1.7 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.4 | 6.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.4 | 1.2 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
| 0.4 | 2.8 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 0.4 | 3.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.4 | 0.8 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.4 | 3.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.4 | 1.2 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.4 | 3.9 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.4 | 2.3 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 0.4 | 5.8 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.4 | 18.6 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.4 | 1.9 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.4 | 1.2 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 0.4 | 1.5 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.4 | 0.4 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 0.4 | 4.2 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.4 | 1.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.4 | 0.4 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
| 0.4 | 3.0 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.4 | 4.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.4 | 3.7 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.4 | 14.4 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.4 | 1.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.4 | 1.1 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.4 | 1.5 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.4 | 4.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.4 | 8.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.4 | 2.5 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.4 | 2.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 0.4 | 12.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.4 | 3.2 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.4 | 0.7 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
| 0.4 | 1.4 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
| 0.4 | 2.1 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.4 | 0.7 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.4 | 2.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.4 | 4.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.4 | 3.2 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.4 | 1.4 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
| 0.3 | 1.4 | GO:0005115 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
| 0.3 | 1.0 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.3 | 4.8 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.3 | 1.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.3 | 2.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.3 | 8.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.3 | 1.7 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.3 | 1.4 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.3 | 3.0 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.3 | 4.0 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.3 | 2.0 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.3 | 2.0 | GO:0070728 | leucine binding(GO:0070728) |
| 0.3 | 1.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.3 | 1.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.3 | 5.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.3 | 1.7 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.3 | 1.6 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.3 | 41.4 | GO:0002039 | p53 binding(GO:0002039) |
| 0.3 | 8.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.3 | 1.9 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.3 | 4.8 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.3 | 0.3 | GO:0019209 | kinase activator activity(GO:0019209) |
| 0.3 | 1.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.3 | 2.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.3 | 1.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.3 | 0.3 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
| 0.3 | 0.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.3 | 1.3 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
| 0.3 | 2.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.3 | 1.9 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 0.3 | 1.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.3 | 1.2 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.3 | 1.2 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 0.3 | 1.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
| 0.3 | 6.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.3 | 10.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.3 | 2.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.3 | 4.9 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.3 | 7.0 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.3 | 1.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.3 | 2.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.3 | 1.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.3 | 1.8 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.3 | 0.9 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
| 0.3 | 2.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.3 | 0.6 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
| 0.3 | 0.9 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 0.3 | 5.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.3 | 2.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.3 | 4.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.3 | 1.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.3 | 1.4 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 0.3 | 2.3 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.3 | 10.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.3 | 0.9 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 0.3 | 0.9 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.3 | 4.3 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.3 | 1.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.3 | 0.6 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
| 0.3 | 7.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.3 | 0.6 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.3 | 1.1 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 0.3 | 7.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.3 | 0.6 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
| 0.3 | 17.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.3 | 9.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.3 | 2.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.3 | 6.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.3 | 1.9 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.3 | 1.1 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.3 | 1.9 | GO:0032557 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) pyrimidine ribonucleotide binding(GO:0032557) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 0.3 | 6.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.3 | 1.4 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.3 | 7.3 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.3 | 3.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.3 | 2.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.3 | 1.4 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.3 | 0.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.3 | 12.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.3 | 3.5 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.3 | 2.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.3 | 2.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.3 | 4.0 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.3 | 0.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.3 | 2.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 0.3 | 0.8 | GO:0030626 | U12 snRNA binding(GO:0030626) |
| 0.3 | 2.1 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.3 | 4.7 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.3 | 7.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.3 | 9.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.3 | 0.8 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.3 | 4.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.3 | 1.0 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.3 | 1.3 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.3 | 0.5 | GO:0038064 | collagen receptor activity(GO:0038064) |
| 0.3 | 1.0 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.3 | 0.8 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.3 | 0.5 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
| 0.2 | 0.7 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.2 | 6.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.2 | 0.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.2 | 6.5 | GO:0031005 | filamin binding(GO:0031005) |
| 0.2 | 0.7 | GO:0015068 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
| 0.2 | 0.7 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
| 0.2 | 1.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.2 | 5.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.2 | 17.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.2 | 2.0 | GO:0042835 | BRE binding(GO:0042835) |
| 0.2 | 12.2 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.2 | 1.7 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 0.2 | 2.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.2 | 7.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.2 | 0.7 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.2 | 1.2 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 0.2 | 0.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.2 | 0.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.2 | 21.5 | GO:0019003 | GDP binding(GO:0019003) |
| 0.2 | 2.1 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.2 | 20.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.2 | 1.6 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.2 | 0.5 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.2 | 4.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.2 | 10.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.2 | 0.7 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
| 0.2 | 0.2 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 0.2 | 2.1 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.2 | 0.7 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
| 0.2 | 1.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.2 | 0.9 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.2 | 0.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.2 | 2.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.2 | 18.1 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.2 | 1.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.2 | 1.8 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.2 | 0.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.2 | 1.3 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.2 | 3.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.2 | 2.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.2 | 1.1 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.2 | 1.5 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.2 | 0.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.2 | 1.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.2 | 3.0 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.2 | 0.4 | GO:0017016 | Ras GTPase binding(GO:0017016) |
| 0.2 | 1.7 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.2 | 2.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 0.2 | 0.8 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 0.2 | 6.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.2 | 6.6 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.2 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.2 | 5.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.2 | 5.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.2 | 0.6 | GO:0008398 | sterol 14-demethylase activity(GO:0008398) |
| 0.2 | 113.0 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.2 | 9.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.2 | 0.8 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 0.2 | 1.0 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.2 | 1.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.2 | 0.8 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.2 | 0.2 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
| 0.2 | 0.8 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
| 0.2 | 0.8 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.2 | 2.6 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.2 | 1.0 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 0.2 | 0.8 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.2 | 0.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.2 | 1.2 | GO:0052840 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.2 | 0.8 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.2 | 10.8 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
| 0.2 | 10.8 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.2 | 0.6 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 0.2 | 0.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.2 | 0.9 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.2 | 1.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.2 | 7.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.2 | 2.3 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.2 | 2.8 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.2 | 0.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.2 | 0.7 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.2 | 1.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.2 | 1.5 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.2 | 2.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.2 | 7.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.2 | 0.5 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
| 0.2 | 2.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.2 | 0.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.2 | 1.1 | GO:0033989 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
| 0.2 | 2.4 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.2 | 0.5 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.2 | 1.0 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.2 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.2 | 4.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.2 | 0.7 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.2 | 0.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.2 | 1.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.2 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.2 | 0.7 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.2 | 0.5 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
| 0.2 | 1.3 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
| 0.2 | 2.7 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.2 | 2.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.2 | 4.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.2 | 1.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.2 | 0.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.2 | 0.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.2 | 1.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.2 | 5.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.2 | 1.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.2 | 0.3 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 0.2 | 0.5 | GO:1904854 | proteasome core complex binding(GO:1904854) |
| 0.2 | 0.6 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.2 | 1.9 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.2 | 1.1 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.2 | 28.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.2 | 1.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.2 | 0.5 | GO:0061598 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
| 0.2 | 0.6 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
| 0.2 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.2 | 0.9 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 0.2 | 0.5 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.2 | 1.7 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
| 0.2 | 1.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.2 | 0.9 | GO:0043426 | MRF binding(GO:0043426) |
| 0.2 | 4.5 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.2 | 4.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.2 | 5.3 | GO:0043236 | laminin binding(GO:0043236) |
| 0.1 | 1.0 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.1 | 0.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.1 | 1.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.1 | 1.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.1 | 3.1 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
| 0.1 | 1.3 | GO:0031386 | protein tag(GO:0031386) |
| 0.1 | 1.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.1 | 1.0 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.1 | 37.5 | GO:0008022 | protein C-terminus binding(GO:0008022) |
| 0.1 | 9.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.1 | 0.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.1 | 0.1 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.1 | 1.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.1 | 0.4 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
| 0.1 | 0.3 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.1 | 0.4 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.1 | 0.4 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.1 | 0.4 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.1 | 0.4 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
| 0.1 | 0.4 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
| 0.1 | 0.9 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.1 | 0.4 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
| 0.1 | 0.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.1 | 0.4 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.1 | 3.2 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 0.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.1 | 1.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.1 | 1.8 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.1 | 0.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.1 | 0.5 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
| 0.1 | 0.5 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
| 0.1 | 0.1 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.1 | 4.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.1 | 0.7 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.1 | 2.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.1 | 1.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.1 | 19.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 1.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.1 | 0.5 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.1 | 2.4 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.1 | 2.0 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.1 | 0.1 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
| 0.1 | 1.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.1 | 0.6 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.1 | 2.2 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.1 | 1.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
| 0.1 | 4.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.1 | 0.5 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
| 0.1 | 0.8 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.1 | 1.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.1 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.1 | 1.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.1 | 1.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 0.7 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.1 | 1.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.1 | 3.3 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
| 0.1 | 1.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 0.1 | 1.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.1 | 0.2 | GO:0097001 | ceramide binding(GO:0097001) |
| 0.1 | 1.0 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
| 0.1 | 1.5 | GO:0009374 | biotin binding(GO:0009374) |
| 0.1 | 1.0 | GO:0008237 | metallopeptidase activity(GO:0008237) |
| 0.1 | 2.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.1 | 0.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.1 | 0.4 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.1 | 6.5 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 4.1 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.1 | 0.5 | GO:0047888 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) fatty acid peroxidase activity(GO:0047888) |
| 0.1 | 2.0 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.1 | 0.1 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
| 0.1 | 0.6 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.1 | 4.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
| 0.1 | 6.7 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.1 | 2.3 | GO:0005112 | Notch binding(GO:0005112) |
| 0.1 | 0.6 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.1 | 0.3 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.1 | 24.3 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.1 | 0.3 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.1 | 9.1 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
| 0.1 | 2.8 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.1 | 0.5 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.1 | 0.4 | GO:0004040 | amidase activity(GO:0004040) |
| 0.1 | 1.0 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.1 | 0.8 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.1 | 0.3 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.1 | 1.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.1 | 5.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 0.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.1 | 0.3 | GO:0004175 | endopeptidase activity(GO:0004175) |
| 0.1 | 0.3 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.1 | 2.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.1 | 0.4 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
| 0.1 | 3.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.1 | 0.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 0.7 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.1 | 1.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.1 | 1.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.1 | 19.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 2.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.1 | 0.3 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.1 | 0.5 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 0.1 | 0.9 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.1 | 2.7 | GO:0015923 | mannosidase activity(GO:0015923) |
| 0.1 | 0.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.1 | 0.5 | GO:0015288 | porin activity(GO:0015288) |
| 0.1 | 0.1 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.1 | 0.5 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 0.1 | 4.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.1 | 4.3 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.1 | 0.8 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.1 | 0.3 | GO:0031775 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
| 0.1 | 4.4 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
| 0.1 | 0.6 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
| 0.1 | 0.4 | GO:0000248 | C-5 sterol desaturase activity(GO:0000248) sterol desaturase activity(GO:0070704) |
| 0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
| 0.1 | 2.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.1 | 0.5 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.1 | 1.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.1 | 0.5 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.1 | 26.2 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
| 0.1 | 1.3 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.1 | 0.8 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.1 | 0.6 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.1 | 1.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.1 | 2.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.1 | 1.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.1 | 0.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.1 | 1.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.1 | 0.3 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
| 0.1 | 0.4 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.1 | 0.8 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.1 | 0.6 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.1 | 3.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.1 | 0.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.1 | 0.5 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.1 | 1.4 | GO:0017022 | myosin binding(GO:0017022) |
| 0.1 | 0.3 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 0.1 | 0.3 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.1 | 0.8 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.1 | 0.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.1 | 0.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.1 | 0.1 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.1 | 3.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.1 | 0.3 | GO:0004423 | iduronate-2-sulfatase activity(GO:0004423) |
| 0.1 | 2.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.1 | 0.4 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.1 | 0.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 0.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 0.1 | 3.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.1 | 0.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.1 | 1.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.1 | 1.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.1 | 2.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 1.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.1 | 1.9 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
| 0.1 | 28.9 | GO:0032561 | guanyl ribonucleotide binding(GO:0032561) |
| 0.1 | 0.9 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
| 0.1 | 0.3 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.1 | 0.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.1 | 0.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.1 | 2.3 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.1 | 0.2 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.1 | 1.9 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.1 | 1.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.1 | 1.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.1 | 1.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 0.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.1 | 5.2 | GO:0003682 | chromatin binding(GO:0003682) |
| 0.1 | 0.3 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.1 | 0.3 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.1 | 0.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.1 | 0.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.1 | 1.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.1 | 4.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.1 | 1.5 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.1 | 0.3 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.1 | 18.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 1.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 0.5 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.1 | 0.2 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.1 | 0.3 | GO:0004775 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
| 0.1 | 125.5 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.1 | 1.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 0.5 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
| 0.1 | 0.3 | GO:0004057 | arginyltransferase activity(GO:0004057) |
| 0.1 | 0.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 0.1 | 0.2 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.1 | 0.4 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.1 | 1.1 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
| 0.1 | 0.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.1 | 0.2 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
| 0.1 | 0.3 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.1 | 0.1 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.1 | 2.5 | GO:0019903 | protein phosphatase binding(GO:0019903) |
| 0.1 | 0.1 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.1 | 0.4 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.1 | 0.4 | GO:0035473 | lipase binding(GO:0035473) |
| 0.1 | 0.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.1 | 2.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 0.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.1 | 0.2 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
| 0.1 | 0.7 | GO:0031402 | sodium ion binding(GO:0031402) |
| 0.1 | 0.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.1 | 3.2 | GO:0032934 | sterol binding(GO:0032934) |
| 0.1 | 0.2 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
| 0.1 | 0.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.1 | 0.1 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.1 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
| 0.1 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
| 0.1 | 1.3 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.1 | 0.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.1 | 0.2 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 0.1 | 0.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.1 | 0.6 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.1 | 0.5 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.1 | 1.0 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.1 | 0.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.1 | 0.2 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
| 0.1 | 4.8 | GO:0005254 | chloride channel activity(GO:0005254) |
| 0.1 | 0.6 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.0 | 7.9 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
| 0.0 | 0.0 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.0 | 0.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.0 | 0.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.0 | 0.2 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.0 | 1.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.0 | 0.1 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 0.0 | 1.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.0 | 0.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.0 | 10.7 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
| 0.0 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.0 | 0.2 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.0 | 0.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
| 0.0 | 1.1 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.0 | 0.3 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 0.0 | 0.3 | GO:0016722 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions(GO:0016722) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.0 | 0.2 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.0 | 0.4 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.0 | 0.1 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
| 0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.0 | 0.3 | GO:0048038 | quinone binding(GO:0048038) |
| 0.0 | 1.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.0 | 0.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.0 | 0.0 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
| 0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.0 | 1.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.0 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
| 0.0 | 0.9 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.0 | 0.1 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.0 | 0.6 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.0 | 10.9 | GO:0003779 | actin binding(GO:0003779) |
| 0.0 | 2.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.0 | 1.9 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
| 0.0 | 0.1 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 0.0 | 3.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.0 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.0 | 0.1 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
| 0.0 | 0.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.0 | 0.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.0 | 0.0 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 0.0 | 1.5 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
| 0.0 | 0.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.0 | 0.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.0 | 0.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.0 | 0.1 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.0 | 0.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.0 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
| 0.0 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.0 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.0 | 0.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.0 | 0.1 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
| 0.0 | 0.2 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.0 | 0.2 | GO:0070026 | nitric oxide binding(GO:0070026) |
| 0.0 | 2.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.0 | 0.0 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.0 | 0.2 | GO:0019207 | kinase regulator activity(GO:0019207) |
| 0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.0 | 0.1 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
| 0.0 | 0.2 | GO:0016594 | glycine binding(GO:0016594) |
| 0.0 | 0.2 | GO:0004691 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) cAMP-dependent protein kinase activity(GO:0004691) |
| 0.0 | 2.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.0 | 0.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.0 | 0.1 | GO:0052724 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
| 0.0 | 1.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 0.1 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.0 | 0.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.0 | 0.1 | GO:0015265 | urea channel activity(GO:0015265) |
| 0.0 | 0.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.0 | 3.4 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
| 0.0 | 0.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.0 | 0.1 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.0 | 0.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.0 | 0.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.0 | 7.9 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
| 0.0 | 0.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.0 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.0 | 0.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.0 | 0.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.0 | 0.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.0 | 0.3 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.0 | 0.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.0 | 0.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.0 | 0.3 | GO:0004386 | helicase activity(GO:0004386) |
| 0.0 | 0.3 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.0 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.0 | 0.0 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 0.0 | 1.1 | GO:0004672 | protein kinase activity(GO:0004672) |
| 0.0 | 0.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.0 | 0.2 | GO:0017048 | Rho GTPase binding(GO:0017048) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.6 | 15.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.5 | 54.7 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.5 | 36.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.4 | 11.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.4 | 25.0 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.4 | 8.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.3 | 14.0 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.3 | 25.5 | PID FOXO PATHWAY | FoxO family signaling |
| 0.3 | 0.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.3 | 1.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.3 | 3.9 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.3 | 5.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.3 | 12.9 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.3 | 13.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.3 | 15.0 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.3 | 30.6 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.2 | 2.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.2 | 11.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.2 | 9.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.2 | 1.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.2 | 5.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.2 | 6.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.2 | 15.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.2 | 2.3 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.2 | 4.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.2 | 0.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.2 | 9.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.2 | 8.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.2 | 3.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.2 | 12.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.2 | 1.9 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.2 | 3.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.2 | 1.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.2 | 9.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.2 | 3.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.2 | 3.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.2 | 8.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.2 | 5.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.1 | 5.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.1 | 1.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.1 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.1 | 3.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.1 | 9.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 1.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.1 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.1 | 0.7 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.1 | 12.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.1 | 11.6 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 2.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.1 | 3.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.1 | 3.3 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.1 | 8.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 9.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.1 | 2.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.1 | 2.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.1 | 14.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.1 | 14.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.1 | 2.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 8.3 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.1 | 4.1 | PID ATM PATHWAY | ATM pathway |
| 0.1 | 1.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 2.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.1 | 2.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.1 | 2.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 0.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.1 | 2.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.1 | 10.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.1 | 3.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.1 | 2.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 7.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 6.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 3.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.1 | 3.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.1 | 2.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 7.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.1 | 5.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 1.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 1.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.1 | 1.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.1 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.1 | 2.6 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.1 | 4.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 3.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.1 | 0.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.1 | 2.8 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.1 | 2.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.1 | 1.8 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.1 | 1.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.1 | 1.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.1 | 1.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 1.4 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.1 | 1.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.1 | 2.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.1 | 2.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 0.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.0 | 0.7 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.0 | 0.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.0 | 0.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 1.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.0 | 2.9 | PID P73PATHWAY | p73 transcription factor network |
| 0.0 | 1.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 0.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.0 | 0.8 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.0 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 0.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.0 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.0 | 1.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.0 | 0.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.0 | 2.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.0 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.0 | 1.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.0 | 1.5 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.0 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.0 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.0 | 0.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 0.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.0 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.0 | 0.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 0.6 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 0.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 0.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 3.9 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.6 | 6.6 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
| 0.6 | 40.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.5 | 1.0 | REACTOME MEMBRANE TRAFFICKING | Genes involved in Membrane Trafficking |
| 0.5 | 11.6 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.5 | 7.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.5 | 2.8 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.4 | 21.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.4 | 15.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.4 | 20.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.4 | 21.3 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.4 | 17.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.4 | 3.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.4 | 0.4 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.4 | 8.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.4 | 4.2 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
| 0.4 | 15.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.4 | 5.6 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.4 | 11.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.4 | 14.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.4 | 0.8 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
| 0.4 | 9.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.4 | 1.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.3 | 9.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.3 | 3.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.3 | 11.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.3 | 14.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.3 | 18.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.3 | 3.5 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.3 | 7.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.3 | 17.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.3 | 7.5 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
| 0.3 | 1.6 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
| 0.3 | 3.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.3 | 6.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.3 | 8.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.3 | 2.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.3 | 24.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.3 | 7.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.3 | 10.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.3 | 3.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.2 | 5.2 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.2 | 2.9 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.2 | 5.2 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
| 0.2 | 0.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.2 | 9.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.2 | 9.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.2 | 13.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.2 | 12.7 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.2 | 10.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.2 | 3.1 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.2 | 3.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.2 | 1.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.2 | 10.3 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.2 | 5.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.2 | 5.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.2 | 3.9 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.2 | 109.9 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.2 | 0.8 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.2 | 4.8 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.2 | 4.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.2 | 3.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.2 | 5.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.2 | 2.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.2 | 0.2 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
| 0.2 | 4.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.2 | 3.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.2 | 3.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.2 | 9.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.2 | 1.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.2 | 3.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.2 | 8.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.2 | 15.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.2 | 1.2 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
| 0.2 | 2.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.1 | 2.8 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.1 | 14.7 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
| 0.1 | 8.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.1 | 3.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.1 | 3.7 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.1 | 4.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.1 | 7.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.1 | 3.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.1 | 1.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.1 | 4.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.1 | 1.8 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.1 | 3.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.1 | 3.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.1 | 3.0 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.1 | 1.8 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
| 0.1 | 1.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 1.7 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.1 | 3.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 0.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.1 | 32.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.1 | 1.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.1 | 2.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.1 | 1.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.1 | 2.4 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.1 | 2.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 2.0 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.1 | 4.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.1 | 11.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.1 | 2.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.1 | 22.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 0.4 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
| 0.1 | 2.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.1 | 1.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.1 | 7.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.1 | 0.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.1 | 0.9 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 0.1 | 1.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.1 | 2.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.1 | 2.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 4.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.1 | 1.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.1 | 1.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.1 | 1.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.1 | 0.6 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.1 | 0.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.1 | 0.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 1.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.1 | 1.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 1.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 0.1 | 1.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.0 | 0.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.0 | 1.6 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
| 0.0 | 0.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.0 | 1.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.0 | 0.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.0 | 2.0 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.0 | 0.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.0 | 3.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.0 | 0.4 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
| 0.0 | 0.9 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
| 0.0 | 0.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.0 | 0.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.0 | 0.5 | REACTOME MEIOSIS | Genes involved in Meiosis |
| 0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.0 | 1.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 1.7 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 0.0 | 1.1 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
| 0.0 | 0.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.0 | 0.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.0 | 0.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.0 | 0.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.0 | 0.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 0.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.0 | 0.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
| 0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.0 | 1.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 0.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 0.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.0 | 2.1 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
| 0.0 | 0.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.0 | 0.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.0 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.0 | 0.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.0 | 0.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.0 | 0.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.0 | 0.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.0 | 0.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.0 | 0.0 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
| 0.0 | 0.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |